Vanberra Signal

DNA Analytics

Curated by Signal

Provider of AI-based gene therapy and diagnostics platform for resecrhers

Overview

Provider of AI-based gene therapy and diagnostics platform. The company has designed products like ACCUMATCH that predicts chemical gene prob matches with its target gene and UNMET MEDICAL NEED that is developed for gene diagnosis, therapy, and editing. The platform provides algorithms to predict chemical gene probes for target genes in gene therapy and for gene diagnosis in cancer, neurological diseases, hematological diseases, retinal diseases, and rare genetic disorders.

Key facts

Founded
2008

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of next-generation of drugs for the treatment of cancer

    Life Sciences TechnologyMenlo Park, United States
  • Portfolio of X-ray and radiology equipment

    Life Sciences TechnologyPlainview, United States
  • Provider of sequencing-based solutions for hospitals

    Life Sciences TechnologyBrooklyn, United States

About DNA Analytics

What does DNA Analytics do?

Provider of AI-based gene therapy and diagnostics platform.

Where is DNA Analytics headquartered?

DNA Analytics is headquartered in Washington, DC, United States.

When was DNA Analytics founded?

DNA Analytics was founded in 2008.

Which sector is DNA Analytics in?

DNA Analytics operates in Life Sciences Technology.

Who are DNA Analytics's competitors?

Companies similar to DNA Analytics include Meliora, JPI Healthcare, and Biotia.